Cargando…

Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants

Background and Objectives: The aim of this study was to investigate the impact of oral administration of the combination of astaxanthin (AXT), lutein, folic acid, vitamin D3, and bromelain with antioxidants on choroidal blood flow in patients with age-related intermediate macular degeneration (AMD)....

Descripción completa

Detalles Bibliográficos
Autores principales: D’Aloisio, Rossella, Di Antonio, Luca, Toto, Lisa, Rispoli, Marco, Di Iorio, Angelo, Delvecchio, Giancarlo, Mastropasqua, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412262/
https://www.ncbi.nlm.nih.gov/pubmed/36013559
http://dx.doi.org/10.3390/medicina58081092
_version_ 1784775450676953088
author D’Aloisio, Rossella
Di Antonio, Luca
Toto, Lisa
Rispoli, Marco
Di Iorio, Angelo
Delvecchio, Giancarlo
Mastropasqua, Rodolfo
author_facet D’Aloisio, Rossella
Di Antonio, Luca
Toto, Lisa
Rispoli, Marco
Di Iorio, Angelo
Delvecchio, Giancarlo
Mastropasqua, Rodolfo
author_sort D’Aloisio, Rossella
collection PubMed
description Background and Objectives: The aim of this study was to investigate the impact of oral administration of the combination of astaxanthin (AXT), lutein, folic acid, vitamin D3, and bromelain with antioxidants on choroidal blood flow in patients with age-related intermediate macular degeneration (AMD). Materials and Methods: Patients affected by intermediate AMD and treated with daily oral nutritional supplement with AXT, bromelain, vitamin D3, folic acid, lutein, and antioxidants for a period of at least 6 months were included in this retrospective study. A control group homogenous for age and sex was also included in the analysis. All participants underwent a complete ophthalmologic examination, spectral domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (OCTA) evaluation. Outcome measures were choroidal thickness (CHT) and choriocapillary vessel density (CCVD) after six months of AXT assumption. Results: CCVD values showed statistically significant difference between cases and controls at baseline (p < 0.001) and in the cases during follow-up (p < 0.001). The CHT measurements showed statistically significant difference between cases and controls (p = 0.002) and in the cases during follow-up (p < 0.001). Conclusions: The combined use of structural OCT and OCTA allows for a detailed analysis in vivo of perfusion parameters of the choriocapillaris and choroid and evaluation of changes of choroidal blood flow after oral nutritional supplements that affect blood flow velocity.
format Online
Article
Text
id pubmed-9412262
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94122622022-08-27 Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants D’Aloisio, Rossella Di Antonio, Luca Toto, Lisa Rispoli, Marco Di Iorio, Angelo Delvecchio, Giancarlo Mastropasqua, Rodolfo Medicina (Kaunas) Article Background and Objectives: The aim of this study was to investigate the impact of oral administration of the combination of astaxanthin (AXT), lutein, folic acid, vitamin D3, and bromelain with antioxidants on choroidal blood flow in patients with age-related intermediate macular degeneration (AMD). Materials and Methods: Patients affected by intermediate AMD and treated with daily oral nutritional supplement with AXT, bromelain, vitamin D3, folic acid, lutein, and antioxidants for a period of at least 6 months were included in this retrospective study. A control group homogenous for age and sex was also included in the analysis. All participants underwent a complete ophthalmologic examination, spectral domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (OCTA) evaluation. Outcome measures were choroidal thickness (CHT) and choriocapillary vessel density (CCVD) after six months of AXT assumption. Results: CCVD values showed statistically significant difference between cases and controls at baseline (p < 0.001) and in the cases during follow-up (p < 0.001). The CHT measurements showed statistically significant difference between cases and controls (p = 0.002) and in the cases during follow-up (p < 0.001). Conclusions: The combined use of structural OCT and OCTA allows for a detailed analysis in vivo of perfusion parameters of the choriocapillaris and choroid and evaluation of changes of choroidal blood flow after oral nutritional supplements that affect blood flow velocity. MDPI 2022-08-12 /pmc/articles/PMC9412262/ /pubmed/36013559 http://dx.doi.org/10.3390/medicina58081092 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
D’Aloisio, Rossella
Di Antonio, Luca
Toto, Lisa
Rispoli, Marco
Di Iorio, Angelo
Delvecchio, Giancarlo
Mastropasqua, Rodolfo
Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants
title Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants
title_full Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants
title_fullStr Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants
title_full_unstemmed Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants
title_short Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants
title_sort choroidal changes in blood flow in patients with intermediate amd after oral dietary supplement based on astaxanthin, bromelain, vitamin d3, folic acid, lutein, and antioxidants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412262/
https://www.ncbi.nlm.nih.gov/pubmed/36013559
http://dx.doi.org/10.3390/medicina58081092
work_keys_str_mv AT daloisiorossella choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants
AT diantonioluca choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants
AT totolisa choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants
AT rispolimarco choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants
AT diiorioangelo choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants
AT delvecchiogiancarlo choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants
AT mastropasquarodolfo choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants